Latest news - Duchenne UK

DMD research

Roche halts clinic studies of delandistrogene moxeparvovec for people who are non-ambulatory

read more Read More
Access to treatments, Policy and campaigning

London Assembly unanimously backs Duchenne UK’s Time is Muscle campaign 

read more Read More
Access to treatments, Policy and campaigning

Delivering Hope: How Leicester’s Early Access Programme Became a Lifeline for Duchenne Patients

read more Read More
Access to treatments, Policy and campaigning

Change of mind at GOSH as they begin dosing givinostat through the Early Access Programme

read more Read More
Access to treatments, Policy and campaigning

Sign up to our Time is Muscle WhatsApp group to stay involved in the campaign

read more Read More
Access to treatments, Policy and campaigning

Duchenne UK joins families in Northern Ireland campaigning for the EAP

read more Read More
Access to treatments, Policy and campaigning

Givinostat recommended for approval in the EU

read more Read More
Duchenne UK news

We are recruiting for a Director of Research and Development

read more Read More
Access to treatments, Policy and campaigning

Second hospital Trust starts dosing with givinostat under Early Access Programme

read more Read More